 |
| January
9, 2026 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- GeneDx and Komodo Health: Partner to
Build the World’s Most Complete Longitudinal
Rare Disease Dataset More
More*
- Senseonics: First Commercial Patients Using
Eversense 365 Continuous Glucose Monitor (CGM)
With twiist Automated Insulin Delivery (AID)
System More
- Welldoc: Submits 510(k) to FDA for
CGM-Informed Glucose Prediction Feature More
|
|
|
|
- Cartesian Therapeutics: Recent Progress and
2026 Outlook More
- Decoding Federal Dollars: Grant
Engine CEO Sam Tetlow on the Evolving
Biohealth Funding Map on BioTalk Podcast
- Emergent BioSolutions: Receives Delivery
Order Up to $21.5 Million to Supply BioThrax
(Anthrax Vaccine Adsorbed) to the U.S.
Department of War in 2026 More
- Get Discounted Access to Exclusive
VC Funding Data from BYTE51
More
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
|
|
 |
 |
| Struggling
to get attention for your
products and services?
Break through with high-impact
marketing content and campaigns |
|
Learn More
→ |
|
|
- BioPharmGuy News: Website Archaeology, Magic
Pills, Sickness is Health, Reverse Food Funnel
More
- In Conversation With Sarah Faizy, Sr Manager
of QC Potency/Residuals at MacroGenics More
- More on FDA Exempting More Wearable, AI
Features From Oversight More
- More on FDA Rejecting Vanda’s Jet
Lag Drug Following Yearslong Dispute and
‘Long-Shot’ Review More*
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The
Big4Bio Podcast: Biotech Showcase
Readies as Biotech Stocks and Deals Pick Up
Podcast
- The Big4Bio Podcast: Every Moment
Matters: DMPK’s Role in Making Better Drugs
and Better Decisions Podcast
- 2025’s Huge FDA Staff Cuts Mostly Didn’t
Impact New Drug Review Timelines, Analysis
Finds
More*
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| M&A
in Life Sciences: The Turning Tide
– Why Now is a Strategic
Inflection for Biopharma and
Biotech |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Biopharmas Axed 47% More Employees Year Over
Year More
- How Industry Trends are Impacting Hiring
Decisions and Leadership Strategies in Life
Sciences More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
